The reiteration of a Buy rating and maintenance of a $26 price target by a reputable analyst like Joseph Stringer from Needham is likely to instill confidence among investors and could positively impact Phathom Pharmaceuticals' stock price in the short term. The specific mention of the price target provides a clear expectation of value, which can influence investor sentiment and trading behavior.